Lixisenatide shows benefits comparable to exenatide in diabetes

06/6/2013 | PhysiciansBriefing.com

Once-daily lixisenatide was as effective as twice-daily exenatide in improving A1C and fasting plasma glucose levels in adult type 2 diabetes patients who showed poor response to metformin, according to a study in Diabetes Care. Researchers also noted lower incidence of symptomatic hypoglycemia and gastrointestinal events among lixisenatide-treated patients than in those who took exenatide. However, the lixisenatide group had less weight loss compared with the exenatide group, researchers said.

View Full Article in:

PhysiciansBriefing.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Clinical Operations
Meridian Health Plan
Detroit, MI
Sr. Director, Regulatory Compliance Intelligence and Outreach
Johnson & Johnson
New Brunswick, NJ
RN Care Manager
MJHS
Brooklyn, NY
Director of Utilization Management
Meridian Health Plan
Chicago, IL
Senior Manager, Healthcare Reform
Avalere Health
Washington, DC